BIOARRAY SOLUTIONS LTD

BIOARRAY SOLUTIONS LTD specializes in the development and manufacturing of in-vitro diagnostic reagents for clinical and transfusion medicine applications. The company’s core technical expertise lies in the formulation, purification, and quality-controlled production of highly specific biochemical reagents used in blood typing, antibody screening, and serological assays. Their work supports critical laboratory workflows in transfusion services and immunohematology, with demonstrated experience delivering precision reagents for complex diagnostic applications. Key differentiators include rigorous adherence to clinical validation protocols, batch-to-batch consistency, and compliance with regulatory standards for diagnostic substance manufacturing under FDA oversight. The company’s focus on targeted reagent development positions it as a niche provider in the clinical diagnostics supply chain. BIOARRAY SOLUTIONS LTD has established a consistent relationship with the Department of Health and Human Services, supplying specialized reagents for transfusion medicine and diagnostic testing programs. Their engagements reflect a trusted partnership in supporting public health laboratories and blood bank operations, where reliability and regulatory compliance are paramount. The nature of their contracts suggests ongoing support for federal blood safety and transfusion compatibility initiatives. The company operates within NAICS 325413, which encompasses the manufacturing of in-vitro diagnostic substances—biochemical materials used to detect disease markers, blood group antigens, and immune responses in laboratory settings. This vertical specialization places them at the intersection of biotechnology and clinical diagnostics, serving a highly regulated market that demands precision, traceability, and sterility in production. BIOARRAY SOLUTIONS LTD is a small business entity headquartered in Warren, New Jersey, with no publicly listed federal certifications. Its geographic presence is concentrated in the northeastern U.S., and its government market positioning is defined by direct, mission-critical supply to federal health agencies requiring high-integrity diagnostic materials.